Presentation by Rick Prinzen, Chief Supply Chain Officer, Canadian Blood Services.
In this presentation, the Canadian Blood Service Distinctive Distribution Network is examined.
Presentation by Navid Choudhury, Senior Manager, Supply Chain Planning, Novo Nordisk.
BEST PRACTICE SHARING: Learn about BPOG’s Collaborative Best- Practice Strategy for Temperature Controlled Transportation Validation.
Check out our end of the day keynote by Merrick Rosenberg, CEO and Co-founder, Take Flight Learning, Author The Chameleon.
Presentation by Julie Carriere, VP Quality Assurance & Regulatory Affairs, Accuristix, a division of ATS
Canada offers challenges to temperature controlled shipments, from the size and breadth of the country to the wide range of temperatures throughout the year. 3PLs distributing across Canada for their clients face unique challenges of complexity that seem difficult to tame. In this presentation:
See results from Eli Lily's biologic shipping study launch exploring how they sent 5 different biologic products on the ocean:
Presentation by Jill Craven, VP Pharmacy Services, Mohawk Medbuy Corporation.
Though life sciences companies see value across the full supply chain, it’s the last mile that matters the most to the customer. With this in mind, we surveyed 150+ pharma logistics leaders to learn more about the key
challenges, solutions and trends impacting the last mile of the life
sciences supply chain.
To be adequately equipped to distribute medicines throughout Canada, pharma firms must be fully educated on the bespoke pain points this region has to offer. Canada’s pharmaceutical market is primed to grow to $25 bn by 2021, according to consulting firm GlobalData. With a 2.5% share of the global market, Canada stands as the 10th largest pharma market. However, Canada has unique complications and hurdles, which greatly complicate the task of distributing temperature sensitive medicines within the region.
In this in-depth whitepaper, we explore the challenges and opportunities associated with achieving temperature supply chain excellence in Canada such as:
Strategic and effective supply chain planning and management can help improve processes, increase cost efficiency and provide a robust, secure end-to-end journey for products. But maintaining GDP compliance whilst ensuring cost efficiency throughout the supply chain can often be challenging; selecting the right partners and solutions, and managing them effectively, is critical in order to avoid unnecessary expenditure from the planning stages right through to the last mile.
We wanted to build an understanding of the areas of the supply chain where the TCL market is overspending, and examine how these areas could be improved to increase cost-effectiveness. This report will analyze the most important considerations when selecting supply chain partners, taking into account the importance of price compared to other elements such as technology and level of service. It will also look into the current barriers to reducing supply chain costs and the new technologies that have the potential to uncover efficiencies in supply chain management.
Experts forecast that 2018 can expect cyber breaches only to get bigger with hackers and technologies getting smarter. This reality forces all organizations to bolster their defences – some are turning to machine-learning based features to automate risk detection by filtering alert data.
Alongside utilising the benefits of digitalization, such as IoT enabled manufacturing and cloud systems, the industry must too understand the cyber security vulnerabilities and respond with the needed precautions. The sensitive data housed by healthcare, pharmaceutical and biotech firms are key targets for hackers. GDPR regulators are predicted to make an example of firms which do not take safeguarding data subjects seriously.
Hit download to continue reading......
Maintaining a high standard of GDP logistics compliance is a difficult task. By following these seven steps, you can:
A typical excursion can take over 40 labor hours to investigate involving multiple departments. Reducing that time by even just 10% per investigation through better collaboration efforts can save hundreds of thousands of dollars for an organization.
Due to the implications of improperly stored drugs, regulator demands have become more stringent and pharmaceutical companies need to be able to prove that their products are not compromised by temperature excursions.
Facing a potential excursion, manufacturers must be able to verify the product status to prevent risking patient safety, but also avoid incurring any unnecessary wastage.
In this report, Pharma IQ spoke exclusively to Saddam Huq, Global QA Senior Manager, Distribution & Cold Chain, GSK Vaccines about temperature excursions on a global scale and managing the risks associated with different regions, freight types and the challenges of data management.
As 2019 CCGF Canada speaker Nedal Ismail, Professor and Program Coordinator Bachelor of Commerce, Supply Chain Management & Management Studies, The Business School, Humber Institute of Technology & Advanced Learning, puts it, though "it is not immediately apparent if blockchain will bring an incremental change (i.e. a marginal improvement in existing processes), or a disruptive change (one that will completely change the way the business is conducted), one thing is clear: blockchain stands to transform pharma logistics over the next decade. From enabling increased transparency, security, communication and efficiency, the potential benefits of blockchain seem limitless.
In this in-depth report, we demystify blockchain by shedding light on:
This whitepapers covers the latest pharmaceutical logistics regulatory developments around the globe related to FMD, MHRA, ICH Q12, PACMP, GMP, DSCSA and more! Designed specifically to keep you up to date with key developments that will shape the compliance agenda. Highlights include:
IQPC is pleased to announce the new Keynote speaker for the 17th Cold Chain Global Forum Canada! Joining the all-star speaker faculty alongside Canadian Blood Services, Sandoz Canada, and Roche Diagnostics is Kimby Barton, Director of the Health Product and Licensing Division (HPIL), Health Products Compliance Directorate at Health Canada’s Regulatory Operation and Regions Branch.
View the press release to learn more about Kimby Barton and her Keynote session.
Have you heard the buzz? Cold Chain Global Forum CANADA is back! While we're hard at work developing our 2019 program, check out our 2018 Post Show Report to find out what you missed last time around. This short event recap includes:
Find out why Cold Chain Global Forum CANADA is the most trusted temperature control supply chain industry event and start building your business case to join us at the next GF Canada taking place February 25-28, 2019 in Toronto, ON.